A firm focus on vaccines stands at the core of everything we do.
We are focused on the research, development and manufacturing of innovative life-saving vaccines
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
The 2024 Annual General Meeting was held on Tuesday, April 16, 2024.